Back
Rules Codeine Cough Syrup Diversion for Intoxication Attracts NDPS Act
The has delivered a significant ruling clarifying that codeine-based cough syrups, even when manufactured with codeine within permissible limits, lose their statutory exemption under the , the moment they are diverted from medicinal use to intoxication. The judgment, delivered by Justice Arun Kumar Singh Deshwal on , settles a recurring legal question in a batch of 77 bail applications, and provides much-needed guidance for pharmaceutical distributors, retailers, and enforcement agencies.
The : Medicinal Use Only
Central to the court’s reasoning was the interpretation of , which exempts certain codeine preparations from the rigour of the NDPS Act. The High Court made it unequivocally clear that this exemption is strictly conditional. The moment a codeine-based cough syrup is stocked, sold, or transported for purposes other than —such as for intoxication—it ceases to be a mere medicinal preparation and is reclassified as a "" under .
Justice Deshwal observed: “Codeine-based cough syrup having permitted quantity of codeine...if stocked, sold or transported for other purposes (like intoxication) instead of medicinal use, would be treated as a codeine preparation under the category of and would attract the provisions of the NDPS Act.” This reaffirms that the statutory shield is not a blanket protection; it is tied to the intended use of the formulation.
Entire Mixture Counts: Hira Singh Applied
In a critical extension of the law, the High Court invoked the ’s landmark ruling in Hira Singh v. Union of India () to determine how the quantity of the contraband should be measured. The court held that when a codeine-based cough syrup is diverted for non-medicinal use, the entire weight of the syrup—not just the pure codeine content—must be taken into account to ascertain whether the quantity is commercial. This is a game-changer for bail jurisprudence under the NDPS Act.
The court stated: “The entire mixture of syrup shall be treated as codeine in view of the judgment of the Hon’ble Apex Court in Hira Singh’s case.” Consequently, if the total weight of the cough syrup preparation exceeds one kilogram, it falls within the definition of "," thereby attracting the stringent bail restrictions under . This interpretation significantly expands the prosecutorial scope in cases involving large volumes of diverted cough syrups.
The Bhola Prasad Case: A Web of Illicit Diversion
The ruling came in the context of allegations against Bhola Prasad, proprietor of in Ranchi, a licensed super stockist under the . According to the materials before the court, Prasad’s firm sold a staggering 7,53,000 bottles of New Phensedyl—each 100 ml bottle containing 10 mg of codeine phosphate—to two purchasing firms: in Sonbhadra and . The purchases occurred between , and .
The investigation revealed that the purchasing firms could not produce any records of receipt, stock, or onward sale. Neighbours stated that the establishments opened only occasionally, and large cash deposits were made by individuals with no apparent connection to the medicine trade. Transporters whose names appeared on e-way bills denied having carried the consignments to Sonbhadra; instead, evidence pointed to the stock moving from Ranchi toward Varanasi and Dhanbad, with later recoveries in Purnia during alleged illegal transportation. Blank signed cheques from the purchasing firms were also recovered, further strengthening the prosecution’s case.
The High Court found material indicating that the medicines were being diverted for intoxication, including evidence suggesting one consignment was intended for onward transportation to Bangladesh.
and : Patterns of Abuse
Similar irregularities surfaced in the case of , which purchased 59,707 bottles from without maintaining purchase, stock, or sale records. E-way bills showed consignments purportedly being sent to nine firms, but the vehicles listed included three-wheelers, school buses, and ambulances—anomalies that the court found highly suspicious. The same batch was later recovered in Tripura and West Bengal during alleged trafficking for intoxication.
In contrast, the court took a more lenient view in cases where the evidence of was thin. For instance, in the matter of , the mere sale of 21,000 bottles of Phencypink-T to 65 retailers, followed by the retailers’ refusal to acknowledge the purchases, was not deemed sufficient to establish an NDPS offence. The court emphasized that courts should not undertake a meticulous examination of commercial transactions at the bail stage, particularly where multiple layers or entities may distance the principal actors from the physical recovery.
Bail Decisions: Drivers and Helpers Freed, Principals Detained
Applying these principles, the High Court granted bail to drivers, helpers, and some retailers where the material did not show that they knowingly participated in diverting the medicines for non-medical use. However, for the main accused like Bhola Prasad, the court found that the threshold was crossed—the total weight of the syrup in his case far exceeded one kilogram—and therefore the under applied, making bail extremely difficult.
The court also expressed concern over the manner in which some NDPS cases had been initiated. It noted with anguish that the Drug Department had, in some instances, lodged NDPS FIRs for what were essentially small licensing violations under the , with incomplete or unnecessary facts. The High Court directed the Commissioner, , to apprise Drug Inspectors of the correct procedure for lodging FIRs, to prevent misuse of the stringent NDPS provisions.
Implications for Pharmaceutical Trade and Enforcement
This judgment provides critical clarity for the pharmaceutical industry. It confirms that routine over-the-counter sales of codeine cough syrups by retailers without a prescription, while a violation of the
, do not automatically attract the NDPS Act. However, the sale of a "huge quantity" within a
"very short span of time"
may indicate that the seller knew the medicines were being diverted for non-medical use, thereby attracting the NDPS Act.
The decision also puts drug inspectors and enforcement agencies on notice: they must carefully distinguish between regulatory infractions and narcotic offences. The High Court’s directive to train officials on proper FIR procedures is a welcome step toward curbing overzealous prosecutions.
Conclusion
The ’s ruling in marks a significant development in the jurisprudence surrounding codeine-based cough syrups and the NDPS Act. By reaffirming the conditional nature of the statutory exemption and applying the Hira Singh principle to entire mixtures, the court has armed prosecutors with a powerful tool to combat the diversion of legitimate medicines into the illicit drug market. At the same time, its caution against treating every licensing irregularity as an NDPS offence ensures that the law remains targeted and proportionate. For legal practitioners and the pharmaceutical trade, this judgment is a must-read.
